LOGIN
ID
PW
MemberShip
2024-12-13 01:14
All News
Policy
Company
Product
Opinion
InterView
°Ë»ö
Dailypharm Live Search
Close
Product
The amount of prescriptions for NSAIDS is increasing rapidly
by
Lee, in-bok
Nov 27, 2020 06:29am
The number of prescriptions for non-steroidal anti-inflammatory drugs (NSAIDS), which are contraindicated for hypertension, asthma patients, and pregnant women, was continuously increasing. Celecoxib took up the most prescription ingredients, and Celebrex recorded the most prescriptions. In particular, Daewon's Pelubi drew attention as it was m
Product
Struggling with dementia drug, A¥â-targeting drug unapproved
by
won-jong-hyuk
Nov 26, 2020 06:03am
Although many of Alzheimer's disease-targeting novel drugs are in development, the market is struggling to receive the health authority approval with troubles found during efficacy validation To this date, multinational pharmaceutical companies have initiated investigation on antibody agents targeting a number of therapeutic targets, such as
Product
A professor reserves thoughts on ¡°90% effective vaccine"
by
Kim, Min-Gun
Nov 16, 2020 06:02am
A U.S. pharmaceutical company Pfizer has attracted a global attention as it announced a COVID-19 vaccine in development has demonstrated an efficacy rate above 90 percent in early results from a Phase 3 trial. One of vaccine experts in South Korea, Professor Seol Dai Wu at Chung-Ang University College of Pharmacy spoke on Nov. 11 at an
Product
Pfizer¡¯s all the items expected to be out of stock?
by
Jung, Heung-Jun
Nov 11, 2020 06:08am
When some local wholesalers sent a text message to the pharmacy saying that all Pfizer items from Pfizer Korea are expected to be sold out, pharmacists are placing large orders to secure stock. The text message the pharmacy received from a wholesaler said that Pfizer stopped placing orders after sales of Pfizer this year, and accordingly,
Product
Comedian Kim Chulmin, doesn¡¯t recommend taking Fenbendazole
by
Kim, Min-Gun
Sep 24, 2020 06:20am
Comedian Kim Chulmin, who aroused hope by taking animal repellent 'Fenbendazole' for anticancer purposes, said, "I will never go back because my condition has deteriorated. I don't want to recommend it to my family." He said that it was over. In an interview with CBS' Kim Hyun-jung's NEWS SHOW on the morning of the 22nd, Kim, who is strugglin
Product
Pharmacies rage on non-refundable price-reduced drug
by
Jung, Heung-Jun
Sep 23, 2020 06:21am
The pricings of four doses of Novartis¡¯ immunosuppressant Certican have been brought down by 30 percent as of Sept. 20, and pharmacies are outraged with the pharmaceutical company refusing to refund the single tablets. Pharmacists are questioning the company¡¯s refund policy as it would solely burden the pharmacies with the differences m
Product
¡°MA and marketer need experience, analytic mind, acumen¡±
by
Kim, Min-Gun
Sep 18, 2020 06:29am
¡°For a Market Access (MA) specialist, the most important skill set is to analyze the clinical trial data and to recreate them as a valuable message. They need to find any missing data required for pharmaceutical reimbursement review, and prepare the evidences prior to the review, if need be. If you are a pharmacy school student and want to beco
Product
10,000 pros & cons for generic substitution
by
Kim, Min-Gun
Sep 10, 2020 06:23am
There are a lot of unusual comments in the National Assembly legislation, where not even a single comment is usually posted. These are the 'Simplification Act for Generic Substitution Post Notification' and 'The Act on Restriction of 1+3 Joint Biological Equivalence'. All of them are laws related to the issue of generc prescription. Among the
Product
Halted fight between government vs. doctors damages both
by
Kang, Shin-Kook
Sep 9, 2020 05:46am
The Korean Medical Association (KMA) has decided to temporarily halt but revisit their discussion with the government and the ruling party on increasing the quota for medical school and establishing public medical school, until COVID-19 is contained. The junior doctors are most likely to return for their duty after the last discussion on Sept. 7
Product
Successful August KMA strike all depends on participation
by
Kang, Shin-Kook
Aug 3, 2020 11:05am
The doctors¡¯ organization objecting against the South Korean government intending to expand medical school admission and provide coverage on Korean herbal medicine are drawing up a plan to call a private clinic doctors¡¯ strike. The strike is most likely to be on Aug. 14. According to Korean Medical Association (KMA) on July 29, the issue o
<
11
12
13
14
15
16
17